(Q82971865)

English

Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7

scientific article published on 17 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lacticaseibacillus casei

1 reference

based on heuristic

inferred from title

13

object named as

Yuji Taketani

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

object named as

Kei Kawana

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

9

object named as

Katsutoshi Oda

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Katsuyuki Adachi

1

object named as

Katsuyuki Adachi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

7

object named as

Kensuke Tomio

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Terufumi Yokoyama

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tomoyuki Fujii

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ayako Tomio

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shiho Miura

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Satoko Kojima

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tomomitsu Sewaki

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Toshiharu Yasugi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shiro Kozuma

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

17 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2810-2817

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Long-term efficacy of human papillomavirus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Development of therapeutic HPV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Antigen sampling across epithelial barriers and induction of mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Analysis of adhesion molecules involved in leukocyte homing into the basolateral pockets of mouse Peyer's patch M cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

[Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Cytotoxic and interferon gamma-producing activities of gamma delta T cells in the mouse intestinal epithelium are strain dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Characterization of lymphocyte response in the female genital tract during ascending Chlamydial genital infection in the guinea pig model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

MAdCAM-1 expressing sacral lymph node in the lymphotoxin beta-deficient mouse provides a site for immune generation following vaginal herpes simplex virus-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Optimism over vaccines administered via mucosal surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.02.005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20170766%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82971865&oldid=2153502535"